You have 9 free searches left this month | for more free features.

carotid atherosclerosis, PET imaging agent

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carotid Atherosclerosis Trial in Saint Louis (Cu[64]-25%-CANF-Comb PET-MR)

Completed
  • Carotid Atherosclerosis
  • Cu[64]-25%-CANF-Comb PET-MR
  • Saint Louis, Missouri
    Washington University in St.Louis
Oct 13, 2022

CANF-Comb-II PET-MR in Atherosclerosis Multisite

Recruiting
  • Carotid Atherosclerosis
  • +2 more
  • Los Angeles, California
  • +1 more
Apr 27, 2023

Hypercholesterolemia, Hypercholesterolemia, Familial Trial in Cambridge (PCSK9 inhibitor, 68Ga-DOTATATE PET-MRI)

Not yet recruiting
  • Hypercholesterolemia
  • +3 more
  • Cambridge, United Kingdom
    University of Cambridge
Jan 13, 2023

Squamous Cell Carcinoma of Head and Neck, Cancer, Carotid Stenosis Trial in Brussels (68GaNOTA-Anti-MMR-VHH2)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +7 more
  • Brussels, Brussel, Belgium
    Uz Brussel
Sep 2, 2022

Carotid Plaque Imaging Project (CPIP)

Recruiting
  • Atherosclerosis
  • Atherosclerotic Plaque
  • Observational study
  • Malmö, Skåne, Sweden
    Skåne University Hospital (SUS)
Apr 18, 2023

Florbetaben for Imaging of Vascular Amyloid

Recruiting
  • Acute Coronary Syndrome
  • +3 more
    • Ottawa, Ontario, Canada
      University of Ottawa Heart Institute
    Oct 13, 2023

    Telerobotic Ultrasound for Carotid Imaging - Feasibility Study

    Withdrawn
    • Carotid Artery Disease
    • +19 more
    • Ultrasound for Carotid Arteries
    • Telerobotic Ultrasound for Carotid Arteries
    • (no location specified)
    Jan 7, 2023

    The Carotid Artery Multi-modality Imaging Prognostic Study

    Recruiting
    • Carotid Artery Diseases
    • +2 more
      • Pisa, Tuscany, Italy
        Azienda Ospedaliero Universitaria Pisana
      Nov 6, 2022

      Carotid Arteries Trial in Los Angeles (PET/CT Imaging with [F-18] RGD-K5)

      Completed
      • Carotid Arteries
      • PET/CT Imaging with [F-18] RGD-K5
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Jul 19, 2022

      Carotid Atherosclerosis Trial in Saint Louis (Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine), Group 2 64CU-DOTA-ECL1i

      Recruiting
      • Carotid Atherosclerosis
      • Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine)
      • Group 2 64CU-DOTA-ECL1i (radioactive imaging medicine)
      • Saint Louis, Missouri
        Washington University CCIR
      Nov 29, 2021

      Coronary Arteriosclerosis Trial in Paris (injection of 68Ga-DOTATATE)

      Terminated
      • Coronary Arteriosclerosis
      • injection of 68Ga-DOTATATE
      • Paris, France
        service de médecine nucléaire-Hôpital Bichat
      Jun 29, 2022

      Marginal Zone Lymphoma Trial ([68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose)

      Not yet recruiting
      • Marginal Zone Lymphoma
      • (no location specified)
      Nov 6, 2023

      Carotid Stenosis Trial in Bron (HITS quantification, Ultrasound examinations, High Resolution MRI)

      Recruiting
      • Carotid Stenosis
      • HITS quantification, Ultrasound examinations, High Resolution MRI
      • Bron, France
        Hospices Civils de Lyon - Service de radiologie
      Mar 30, 2022

      Aortic Aneurysm, Abdominal, Carotid Atherosclerosis Trial in Stanford (drug, device, procedure)

      Withdrawn
      • Aortic Aneurysm, Abdominal
      • Carotid Atherosclerosis
      • Stanford, California
        Stanford University
      May 19, 2021

      Prostate Cancer Trial in Bala-Cynwyd (rhPSMA-7.3 (18F))

      Not yet recruiting
      • Prostate Cancer
      • rhPSMA-7.3 (18F)
      • Bala-Cynwyd, Pennsylvania
        MidLantic Urology
      Mar 22, 2023

      Malignant Brain Tumors Trial in Berkel en Rodenrijs (procedure, device, other)

      Recruiting
      • Malignant Brain Tumors
      • intra-arterial injection
      • +2 more
      • Berkel en Rodenrijs, Zuid Holland, Netherlands
        Laurens Groenendijk
      Apr 3, 2023

      Carotid Intraplaque Neovascularization Combined With Stress Echo

      Recruiting
      • Atherosclerosis
      • +5 more
      • Carotid Contrast Enhanced Ultrasound
      • Calgary, Alberta, Canada
      • +3 more
      Jun 8, 2022

      Prostate Cancer, Recurrent Prostate Cancer Trial in Tampa (F-DCFPyL Injection, PSMA PET)

      Recruiting
      • Prostate Cancer
      • Recurrent Prostate Cancer
      • F-DCFPyL Injection
      • PSMA PET
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Jan 24, 2023

      Carotid Stenosis, Carotid Artery Diseases, Carotid Atherosclerosis Trial in Paris (contrast enhanced ultrafast ultrasound

      Recruiting
      • Carotid Stenosis
      • +4 more
      • contrast enhanced ultrafast ultrasound imaging
      • Paris, France
        Hopital europeen Georges-Pompidou
      Nov 15, 2021

      Metastatic Cancer, Carcinoma, Adenocarcinoma Trial in Cleveland (18F-Clofarabine)

      Recruiting
      • Metastatic Cancer
      • +2 more
      • Cleveland, Ohio
        Cleveland Clinic, Case Comprehensive Cancer Center
      May 11, 2022

      An Imaging Agent With Positron Emission Tomography/Magnetic

      Recruiting
      • Recurrent Soft Tissue Sarcoma
      • +2 more
      • Fluorodopa F 18
      • +4 more
      • Jacksonville, Florida
        Mayo Clinic in Florida
      Jan 4, 2023

      Ischemic Heart Disease (IHD) Trial in Tianjin (XTR003)

      Completed
      • Ischemic Heart Disease (IHD)
      • Tianjin, Tianjin, China
        TEDA International Cardiovascular Hospital
      May 23, 2023

      Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in San Francisco (drug, biological, procedure)

      Recruiting
      • Prostate Cancer
      • Metastatic Castration-resistant Prostate Cancer
      • San Francisco, California
        University of California, San Francisco
      Mar 29, 2022

      Extramedullary Myeloma Trial in Melbourne (Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent)

      Not yet recruiting
      • Extramedullary Myeloma
      • Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent
      • Melbourne, Victoria, Australia
        Peter MacCallum Cancer Centre
      Dec 18, 2022